18+ ONLY · LAB RESEARCH ONLY · NOT FOR HUMANS OR ANIMALS

UK-BASED SUPPLIER · ESTABLISHED 2023

Research peptides in the UK, verified by third-party analysis.

Supplied to independent researchers, academic laboratories, and accredited institutions. Purity verified by HPLC and mass spectrometry on every batch.

≥98%

HPLC PURITY

3pm

DISPATCH CUT-OFF

-20°C

COLD CHAIN

COA

PER BATCH

CATALOGUE

Most studied compounds

View all 23 →
ABOUT BSR

Research peptides in the UK

Biotech Scientific Research supplies research-grade peptides to laboratories and independent researchers across the UK. Every batch is verified by HPLC and mass spectrometry, and every peptide order comes with the certificate of analysis for its lot.

Orders placed before 3pm Monday to Friday are dispatched the same day. Every compound is sold for laboratory research only. Buyers must be 18 or over and confirm at checkout that nothing will be used on humans or animals.

Browse the full catalogue, read how each batch is tested, check delivery times or work out concentrations with the peptide calculator.

BSR INTELLIGENCE

Latest from the peptide industry

All briefings →

Research Pipeline

Avexitide Phase 3 LUCIDITY Results and the FDA's Class-Wide NAION Warning: What GLP-1 Receptor Pharmacology Looks Like in Both Directions

Phase 3 LUCIDITY data for avexitide, a first-in-class GLP-1 receptor antagonist, showed a 55% reduction in dangerous hypoglycaemic events in post-bariatric patients — establishing the receptor as a therapeutic target from both sides. Meanwhile, the FDA has mandated class-wide label warnings on all GLP-1 agonists for a rare but serious optic neuropathy, adding a new safety variable for research procurement teams to track.

21 Nov 2026

Industry & Community

HHS Enforcement Discretion in Action: Hims & Hers Launches Peptides+, argenx Bets $1.15 Billion on Oral Macrocyclics

Three weeks after the HHS enforcement discretion policy took effect, the first large commercial platform has entered the compounded peptide market. Separately, argenx's $1.15 billion acquisition of Unnatural Products signals where serious capital is moving in oral peptide drug development — with implications for how procurement professionals should read the current landscape.

20 Nov 2026

Reputational Risks

Bacterial Contamination in Seized Peptide Vials, Adverse Event Data and the "Research Use Only" Label: A Procurement Risk Assessment

Health Canada seized more than 11,400 contaminated vials from a Chinese peptide supplier in early November, while US health professionals cited two retatrutide-linked deaths and over 1,700 adverse events linked to compounded GLP-1 peptides. Against that backdrop, Hims & Hers launched its Peptides+ platform on 18 November — a sequence of events that illustrates the supply-chain and provenance risks facing research procurement teams sourcing peptides through unverified channels.

19 Nov 2026

HPLC analysis instrument
01 · DOCUMENTATION

Every batch, documented.

HPLC purity analysis, mass spectrometry confirmation, and batch traceability — downloadable per product, matched to the batch code on your vial.

View our methodology →
Research vials in storage rack
02 · STORAGE

Cold chain maintained.

Lyophilised product held at -20°C in temperature-controlled storage from receipt to dispatch. Stability guaranteed under documented conditions.

Storage protocols →
Research compound vials ready for dispatch
03 · DISPATCH

Same-day, plain packaging.

Orders placed before 3pm, Monday to Friday, dispatched the same working day. Tracked UK delivery, discreet unbranded packaging as standard.

Shipping & returns →